Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
Join us for a discussion that focuses on the international legislative mechanisms that regulated countries have used to address their obligations under the UN Single Convention.
Recent developments have convinced many that the DEA will seek to transfer cannabis to schedule III of the Controlled Substances Act soon. Yet the mechanics of the administrative process and the implications of the proposed change are not well understood. Our panel will discuss the role of other federal agencies in the scheduling review process, the legal implications of cannabis’s scheduling status under federal law, and the implications rescheduling would have for state-regulated cannabis markets, FDA enforcement, and more.
This session will provide you with practice and practical advice on how to conduct due diligence on an IP portfolio in various types of transactions. The panel will identify top diligence issues so you can spot them in the next transaction you handle, and we'll discuss how to address them.
Social Equity: Social Equity and Justice for the Indigenous Community. This CLE will focus on social equity and social justice issues within the indigenous community. Speakers will discuss tribal sovereignty, federal and state recognized tribes and barriers to entry for indigenous tribes into the cannabis industry.
In this session, hear from attorneys who are actively working on applications in the Garden State and with clients who are investing in New Jersey or otherwise gearing up for future submissions. Learn about unique-to-New Jersey license types, such as the “Conditional License,” enabling prospective operators to apply for a license without site control (subject to income restrictions), the “Micro-license,” a 2500 square foot facility for which there are no caps (subject to residency requirements), priorities in licensing, and creative opportunities to participate in the market distinct from ownership (via “Financial Source Agreement” or “Management Services Agreement”). Also learn about how the regulatory process is unfolding and how administrative delays are impacting the licensing process and accompanying operational timelines and legal transactions.